Prostaxen 60 mg Capsule
Generic Name: Enzalutamide
Brand Name: Prostaxen
Strength: 60 mg
Form: Soft Gelatin Capsule
Pack Size: 4 or 120 capsules per bottle (varies)
Manufacturer: Everest Pharmaceuticals
Distributed by: NP Molecule
Indications:
Prostaxen (Enzalutamide) is indicated for the treatment of:
-
Metastatic castration-resistant prostate cancer (mCRPC)
-
Non-metastatic castration-resistant prostate cancer (nmCRPC)
-
Metastatic castration-sensitive prostate cancer (mCSPC)
It is used in combination with androgen deprivation therapy (ADT) or as monotherapy in certain advanced cases.
Pharmacology:
Enzalutamide is an androgen receptor inhibitor. It works by:
-
Blocking androgen receptor signaling pathways.
-
Preventing androgens (like testosterone) from binding and stimulating prostate cancer cell growth.
This results in slowed disease progression and improved survival in prostate cancer patients.
Dosage & Administration:
-
Recommended dose: 160 mg once daily (usually 4 × 40 mg capsules or equivalent in 60 mg dosing).
-
Can be taken with or without food.
-
Dose adjustments may be required in liver impairment or with strong enzyme inducers.
Drug Interactions:
-
Enzalutamide is a CYP3A4 inducer, and may reduce the efficacy of other medications.
-
Avoid use with sensitive CYP substrates or strong CYP inducers.
Contraindications:
Side Effects:
-
Common: Fatigue, hot flashes, hypertension, back pain.
-
Serious: Seizures (rare), falls, cardiovascular events.
Pregnancy & Lactation:
Precautions & Warnings:
-
Risk of seizure—caution in patients with seizure history.
-
Monitor blood pressure regularly.
-
Patients should use effective contraception during and after treatment.
Overdose Effects:
Therapeutic Class:
Storage Conditions: